Viral infections alter host cell metabolism and homeostasis; however, the mechanisms that
regulate these processes have only begun to be elucidated. We report here that Zika virus …

The first outbreak of Zika virus (ZIKV) infection in the Americas, especially in Brazil, was
reported in 2015. Fever, headache, rash, and conjunctivitis are the common symptoms of …

Zika virus (ZIKV) has emerged as a global health issue, yet neither antiviral therapy nor a
vaccine are available. ZIKV is an enveloped RNA virus, replicating in the cytoplasm in close …

Zika virus (ZIKV) is an emerging virus causally linked to neurological disorders, including
congenital microcephaly and Guillain–Barré syndrome. There are currently no targeted …

Zika virus (ZIKV) has emerged as a global health threat due to its neuro-teratogenic effect
and wide range of transmission routes. Most recently, ZIKV infection has been linked with …

Owing to the widespread distribution of mosquitoes capable of transmitting Zika virus, lack of
clinical vaccines and treatments, and poor immunity of populations to new infectious …

The Zika fever is an arboviral disease resulting from the infection with Zika virus (ZIKV). The
virus is transmitted to humans by the bite of Aedes mosquitos, mainly Aedes aegypti and …

Zika virus (ZIKV) infection is a serious public health concern. ZIKV infection has been
associated with increased occurrences of microcephaly among newborns and incidences of …

Zika virus (ZIKV) has emerged as a significant public health threat, reaching pandemic
levels in 2016. Human infection with ZIKV can manifest as either asymptomatic or as an …

The recurring outbreak of Zika virus (ZIKV) worldwide makes an emergent demand for novel,
safe and efficacious anti-ZIKV agents. ZIKV non-structural protein 5 (NS5) methyltransferase …